Thrum, Stephan <br/><br/>
Polo-like kinase 1 inhibition as a new therapeutic modality in therapy of cholangiocarcinoma.  [electronic resource] 

 -  Anticancer research  Oct 2011 
 - 3289-99 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Cycle--drug effects<br/>Cell Cycle Proteins--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cholangiocarcinoma--drug therapy<br/>Deoxycytidine--analogs & derivatives<br/>Fluorouracil--pharmacology<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Pteridines--pharmacology<br/>Pyrimidines--pharmacology<br/>Pyrroles--pharmacology<br/>RNA, Messenger--genetics<br/>Gemcitabine<br/>Polo-Like Kinase 1